Korean Drug Co. Ltd (014570) - Total Liabilities

Latest as of June 2026: ₩20.08 Billion KRW ≈ $13.61 Million USD

Based on the latest financial reports, Korean Drug Co. Ltd (014570) has total liabilities worth ₩20.08 Billion KRW (≈ $13.61 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Korean Drug Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Korean Drug Co. Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Korean Drug Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Korean Drug Co. Ltd asset portfolio.

Korean Drug Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Korean Drug Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Compania Introductora de Buenos Aires SA BA:INTR	Argentina	AR$41.97 Billion
iBio, Inc. Common Stock NYSE MKT:IBIO	USA	$8.12 Million
Ion Video Ltd AU:IOV	Australia	AU$2.81 Million
Pelayaran Nasional Bina Buana Raya JK:BBRM	Indonesia	Rp4.20 Million
SIAV S.P.A. F:F4U	Germany	€40.55 Million
Worth Peripherals Limited NSE:WORTHPERI	India	Rs734.51 Million
Optimi Health Corp. Common Shares NASDAQ:OPTH	USA	$5.79 Million
BIONXT SOLUTIONS INC. F:BXT	Germany	€7.65 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Korean Drug Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Korean Drug Co. Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Korean Drug Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Korean Drug Co. Ltd (2014–2025)

The table below shows the annual total liabilities of Korean Drug Co. Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩11.25 Billion ≈ $7.62 Million	+4.32%
2024-12-31	₩10.78 Billion ≈ $7.31 Million	-14.56%
2023-12-31	₩12.62 Billion ≈ $8.55 Million	+28.72%
2022-12-31	₩9.80 Billion ≈ $6.64 Million	-17.77%
2021-12-31	₩11.92 Billion ≈ $8.08 Million	-4.42%
2020-12-31	₩12.47 Billion ≈ $8.45 Million	+15.50%
2019-12-31	₩10.80 Billion ≈ $7.32 Million	+6.27%
2018-12-31	₩10.16 Billion ≈ $6.89 Million	+3.48%
2017-12-31	₩9.82 Billion ≈ $6.66 Million	+0.73%
2016-12-31	₩9.75 Billion ≈ $6.61 Million	+2.42%
2015-12-31	₩9.52 Billion ≈ $6.45 Million	-28.88%
2014-12-31	₩13.38 Billion ≈ $9.07 Million	--

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$24.94 Million

₩36.81 Billion KRW

Market Cap Rank

#24478 Global

#1752 in Korea

Share Price

₩3400.00

Change (1 day)

+0.74%

52-Week Range

₩3120.00 - ₩4630.00

All Time High

₩13030.58